IP Library Granted Patent US 9,937,123
Granted Patent B2
US 9,937,123 · App. 15/414,046 · Granted Apr 10, 2018

Rapidly disintegrating films for delivery of pharmaceutical or cosmetic agents

Inventors: Scott D. Barnhart (York, PA); Andrew P. Full (State College, PA); Cathy M. Moritz (Red Lion, PA)
Assignee: ADHESIVES RESEARCH, INC.
A61K9/006A61K9/7007A61K31/485A61K47/26A61K47/32A61K47/34A61K47/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,937,123
App. No.
15/414,046
Granted
Apr 10, 2018
Kind
B2
Abstract

A dissolvable film for delivering a pharmaceutical agent comprises a first water soluble polymer in an amount of from 2 to 35 weight percent and having a molecular weight from about 5,000 daltons to about 49,000 daltons; a second water soluble polymer in an amount of from 2 to 35 weight percent and having a molecular weight greater than 60,000 daltons; and a pharmaceutically active ingredient. The film has a thickness of about 20 microns to about 1200 microns and is configured to disintegrate after contact with a mucous membrane and thereby release the active ingredient.

Claims (28)

1. A dissolvable film for delivering a pharmaceutical agent, comprising:

a first water soluble polymer in an amount of from 2 to 35 weight percent and having a molecular weight from about 5,000 daltons to about 49,000 daltons;

a second water soluble polymer in an amount of from 2 to 35 weight percent and having a molecular weight greater than 60,000 daltons; and

a pharmaceutically active ingredient;

wherein the film has a thickness of about 20 microns to about 1200 microns and is configured to disintegrate within about a minute after contact with a mucous membrane and thereby release the active ingredient.

2. The film of claim 1 wherein the active ingredient is selected from the group consisting of non-steroidal anti-inflammatories, opiate agonists, anesthetic/analgesics, and central nervous system agents.

3. The film of claim 1 wherein the second water soluble polymer has a molecular weight of about 60,000 to about 500,000 daltons.

4. The film of claim 1 wherein at least one of the water soluble polymers comprises poly(ethylene) oxide.

5. The film of claim 1 wherein at least one of the water soluble polymers comprises polyvinylpyrrolidone.

6. The film of claim 1 wherein the first water soluble polymer and the second water soluble polymer are different formulas.

7. The film of claim 1 further comprising a third water soluble polymer.

8. The film of claim 1 wherein the film is mucoadhesive.

9. The film of claim 1 wherein the film disintegrates within about 20 to 60 seconds after contact with a mucous membrane.

10. The film of claim 1 further comprising a starch component.

11. The film of claim 10 wherein the concentration of the starch component is about 2% to 50% of the weight of the film.

12. The film of claim 1 further comprising a glucose component.

13. The film of claim 12 wherein the concentration of the glucose component is about 2% to 20% of the weight of the film.

14. The film of claim 1 further comprising a plasticizer, a humectant, or both.

15. The film of claim 14 wherein the combined amount of the plasticizer and humectant is about 3% to 30% of the weight of the film.

16. The film of claim 1 further comprising a filler.

17. The film of claim 1 wherein the active ingredient is a taste masked drug.

18. The film of claim 1 wherein the concentration of the first water soluble polymer is about 2% to 10% of the weight of the film and wherein the concentration of the second water soluble polymer is about 2% to 10% of the weight of the film.

19. A dissolvable film for delivering a pharmaceutical or cosmetic agent, comprising:

a first water soluble polymer comprising polyvinylpyrrolidone having a molecular weight from about 5,000 daltons to about 49,000 daltons;

a second water soluble polymer comprising poly(ethylene) oxide having a molecular weight greater than 60,000 daltons; and

a pharmaceutically active ingredient;

wherein the film has a thickness of about 20 microns to about 1200 microns and is configured to disintegrate within about a minute after contact with a mucous membrane and thereby release the active ingredient.

20. The film of claim 1 , wherein the active ingredient is sumatriptan.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2017
From: BARNHART, SCOTT D.; FULL, ANDREW P.; MORITZ, CATHY M.
To: ADHESIVES RESEARCH, INC.
Reel/Frame 041065/0607 →
Continuity (4)
Continuation 13709775 · Dec 10, 2012
Continuation 10970391 · Oct 22, 2004
Provisional Application 60513547 · Oct 24, 2003
Related Publication 20170128358A1 · May 11, 2017